Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
Delhi Patent Office Refuses Patent on Pediatric Aids Drug Nevirapine Hemiydrate
USPTO Confirms the Validity of a Second Tenofovir Patent
Gilead Announces that USPTO to Uphold One of the Viread Patents
Tenofovir Patent Takes Another Hit
Experts Discuss Policy On Patent Landscapes For Life Sciences – By Kaitlin Mara of IP Watch
Patent Landscaping Report on Neglected Human Diseases
India Cancer Patients Seek To Use Courts For Access To Patented Drugs – By Tatum Anderson of IP Watch
Country Watch: Nigeria
The Battle for Erlotinib – High Court Decision Raises a Number of Procedural and Practice Issues
Tussle Over Participation In India Compulsory Licence Hearing – IP Watch By Tatum Anderson